Showing results (1641-1650 of 31,365) with videos related to
Sort By:
Pageof 3,137
Journal of Medicinal Chemistry|May 1, 1986
Structurally specific binding of halogenated biphenyls to thyroxine transport proteinU Rickenbacher, J D McKinney, S J Oatley, et al.Journal of Medicinal Chemistry|May 1, 1986
Conformational effects on the activity of drugs. 11. Stereostructural models for the direct activation of the alpha- and beta-adrenergic receptorB Macchia, A Balsamo, E Epifani, et al.Journal of Medicinal Chemistry|July 3, 2018
Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant VariantJian Zhang, Vasanthanathan Poongavanam, Dongwei Kang, et al.Journal of Medicinal Chemistry|July 4, 2018
De Novo Design, Synthesis, and Biological Evaluation of 3,4-Disubstituted Pyrrolidine Sulfonamides as Potent and Selective Glycine Transporter 1 Competitive InhibitorsYing Wang, Hongyu Zhao, Jason T Brewer, et al.Journal of Medicinal Chemistry|July 4, 2018
Contilisant, a Tetratarget Small Molecule for Alzheimer's Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism ProfileÓscar M Bautista-Aguilera, Josiane Budni, Francielle Mina, et al.Journal of Medicinal Chemistry|May 25, 2018
Docking Screens for Dual Inhibitors of Disparate Drug Targets for Parkinson's DiseaseMariama Jaiteh, Alexey Zeifman, Marcus Saarinen, et al.Journal of Medicinal Chemistry|July 18, 2018
Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain InhibitorYujun Zhao, Bing Zhou, Longchuan Bai, et al.Journal of Medicinal Chemistry|July 18, 2018
Discovery, Synthesis, Pharmacological Profiling, and Biological Characterization of Brintonamides A-E, Novel Dual Protease and GPCR Modulators from a Marine CyanobacteriumFatma H Al-Awadhi, Bowen Gao, Mohammad A Rezaei, et al.Journal of Medicinal Chemistry|July 19, 2018
Development of Novel Monoamine Oxidase-B (MAO-B) Inhibitors with Reduced Blood-Brain Barrier Permeability for the Potential Management of Noncentral Nervous System (CNS) DiseasesRonan Gealageas, Alice Devineau, Pauline P L So, et al.Journal of Medicinal Chemistry|July 19, 2018
Structure-Function Analysis of Immune Checkpoint Receptors to Guide Emerging Anticancer ImmunotherapyRita C Acúrcio, Anna Scomparin, João Conniot, et al.Pageof 3,137